Sales Rep Overtime Might Get Supreme Court Review; "Staggering Retroactive Liability" Is Worry
This article was originally published in The Pink Sheet Daily
Executive Summary
The court will consider certiorari petitions from Novartis and Schering at its Feb. 18 conference. An amicus brief from PhRMA paints a dire picture.